TRIM8: a Double-edged Sword in Glioblastoma with the Power to Heal or Hurt

Overview

Journal Cell Mol Biol Lett

Publisher Biomed Central

Specialties Biochemistry
Cell Biology
Molecular Biology

Date 2023 Jan 23

PMID 36690946

Authors

Hamed Hosseinalizadeh

Omid Mohamadzadeh

Mohammad Saeed Kahrizi

Zahra Razaghi Bahabadi

Daniel J Klionsky

Hamed Mirzei

Affiliations

Soon will be listed here.

Abstract

Glioblastoma multiforme (GBM) is an aggressive primary brain tumor and one of the most lethal central nervous system tumors in adults. Despite significant breakthroughs in standard treatment, only about 5% of patients survive 5 years or longer. Therefore, much effort has been put into the search for identifying new glioma-associated genes. Tripartite motif-containing (TRIM) family proteins are essential regulators of carcinogenesis. TRIM8, a member of the TRIM superfamily, is abnormally expressed in high-grade gliomas and is associated with poor clinical prognosis in patients with glioma. Recent research has shown that TRIM8 is a molecule of duality (MoD) that can function as both an oncogene and a tumor suppressor gene, making it a "double-edged sword" in glioblastoma development. This characteristic is due to its role in selectively regulating three major cellular signaling pathways: the TP53/p53-mediated tumor suppression pathway, NFKB/NF-κB, and the JAK-STAT pathway essential for stem cell property support in glioma stem cells. In this review, TRIM8 is analyzed in detail in the context of GBM and its involvement in essential signaling and stem cell-related pathways. We also discuss the basic biological activities of TRIM8 in macroautophagy/autophagy, regulation of bipolar spindle formation and chromosomal stability, and regulation of chemoresistance, and as a trigger of inflammation.

Citing Articles

Unveiling the Dichotomy of Urinary Proteins: Diagnostic Insights into Breast and Prostate Cancer and Their Roles.

Feng Y, Huo Q, Li B, Yokota H Proteomes. 2024; 12(1).

PMID: 38250812 PMC: 10801584. DOI: 10.3390/proteomes12010001.

Multipronged regulation of autophagy and apoptosis: emerging role of TRIM proteins.

Ahsan N, Shariq M, Surolia A, Raj R, Khan M, Kumar P Cell Mol Biol Lett. 2024; 29(1):13.

PMID: 38225560 PMC: 10790450. DOI: 10.1186/s11658-023-00528-8.

Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination.

Wang L, Li H, Huang A, Zhao Y, Xiao C, Dong J Oncogene. 2023; 42(50):3708-3718.

PMID: 37914816 DOI: 10.1038/s41388-023-02879-0.

Regulating the regulatory T cells as cell therapies in autoimmunity and cancer.

Hosseinalizadeh H, Rabiee F, Eghbalifard N, Rajabi H, Klionsky D, Rezaee A Front Med (Lausanne). 2023; 10:1244298.

PMID: 37828948 PMC: 10565010. DOI: 10.3389/fmed.2023.1244298.

Single-cell RNA sequencing in juvenile idiopathic arthritis.

Luo X, Tang X Genes Dis. 2023; 11(2):633-644.

PMID: 37692495 PMC: 10491939. DOI: 10.1016/j.gendis.2023.04.014.

References

Toniato E, Chen X, Losman J, Flati V, Donahue L, Rothman P . TRIM8/GERP RING finger protein interacts with SOCS-1. J Biol Chem. 2002; 277(40):37315-22. DOI: 10.1074/jbc.M205900200. View

Yang Q, Zhao J, Chen D, Wang Y . E3 ubiquitin ligases: styles, structures and functions. Mol Biomed. 2022; 2(1):23. PMC: 8607428. DOI: 10.1186/s43556-021-00043-2. View

Aynaud M, Mirabeau O, Gruel N, Grossetete S, Boeva V, Durand S . Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution. Cell Rep. 2020; 30(6):1767-1779.e6. DOI: 10.1016/j.celrep.2020.01.049. View

Mafi A, Rahmati A, Babaei Aghdam Z, Salami R, Salami M, Vakili O . Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment. Cell Mol Biol Lett. 2022; 27(1):65. PMC: 9347108. DOI: 10.1186/s11658-022-00354-4. View

Zhong Z, Umemura A, Sanchez-Lopez E, Liang S, Shalapour S, Wong J . NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell. 2016; 164(5):896-910. PMC: 4769378. DOI: 10.1016/j.cell.2015.12.057. View

Jamil S, Lam I, Majd M, Tsai S, Duronio V . Etoposide induces cell death via mitochondrial-dependent actions of p53. Cancer Cell Int. 2015; 15:79. PMC: 4527242. DOI: 10.1186/s12935-015-0231-z. View

Okumura F, Okumura A, Matsumoto M, Nakayama K, Hatakeyama S . TRIM8 regulates Nanog via Hsp90β-mediated nuclear translocation of STAT3 in embryonic stem cells. Biochim Biophys Acta. 2011; 1813(10):1784-92. DOI: 10.1016/j.bbamcr.2011.05.013. View

Tarasov K, Tarasova Y, Tam W, Riordon D, Elliott S, Kania G . B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. PLoS One. 2008; 3(6):e2478. PMC: 2423619. DOI: 10.1371/journal.pone.0002478. View

Farina F, Pierobon P, Delevoye C, Monnet J, Dingli F, Loew D . Kinesin KIFC1 actively transports bare double-stranded DNA. Nucleic Acids Res. 2013; 41(9):4926-37. PMC: 3643607. DOI: 10.1093/nar/gkt204. View

10.

Marzano F, Caratozzolo M, Pesole G, Sbisa E, Tullo A . TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance. Biomedicines. 2021; 9(3). PMC: 7997459. DOI: 10.3390/biomedicines9030241. View

11.

Motzer R, Escudier B, Tomczak P, Hutson T, Michaelson M, Negrier S . Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial. Lancet Oncol. 2013; 14(6):552-62. DOI: 10.1016/S1470-2045(13)70093-7. View

12.

Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C . p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol. 2009; 29(10):2594-608. PMC: 2682036. DOI: 10.1128/MCB.01396-08. View

13.

Ji J, Ding K, Luo T, Zhang X, Chen A, Zhang D . TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα. Cell Death Differ. 2020; 28(1):367-381. PMC: 7853150. DOI: 10.1038/s41418-020-00606-w. View

14.

Roy M, Tomar D, Singh K, Lakshmi S, Prajapati P, Bhatelia K . TRIM8 regulated autophagy modulates the level of cleaved Caspase-3 subunit to inhibit genotoxic stress induced cell death. Cell Signal. 2018; 48:1-12. DOI: 10.1016/j.cellsig.2018.04.003. View

15.

Marshall G, Bell J, Koach J, Tan O, Kim P, Malyukova A . TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells. Oncogene. 2010; 29(46):6172-83. PMC: 3007621. DOI: 10.1038/onc.2010.340. View

16.

Tomar D, Sripada L, Prajapati P, Singh R, Singh A, Singh R . Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-κB pathway. PLoS One. 2012; 7(11):e48662. PMC: 3495970. DOI: 10.1371/journal.pone.0048662. View

17.

Mulcahy Levy J, Thorburn A . Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ. 2019; 27(3):843-857. PMC: 7206017. DOI: 10.1038/s41418-019-0474-7. View

18.

Zhou X, Yang Y, Ma P, Wang N, Yang D, Tu Q . TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway. J Neurooncol. 2019; 145(2):211-222. DOI: 10.1007/s11060-019-03301-0. View

19.

Cai Y, Gu W, Cheng K, Jia P, Li F, Wang M . Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner. Biochem Biophys Res Commun. 2021; 550:134-141. DOI: 10.1016/j.bbrc.2021.02.098. View

20.

Di K, Linskey M, Bota D . TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth. Oncogene. 2012; 32(42):5038-47. PMC: 3766389. DOI: 10.1038/onc.2012.531. View